Канада - Енглески - Health Canada

juno pharmaceuticals corp. - micafungin (micafungin sodium) - powder for solution - 100mg - micafungin (micafungin sodium) 100mg

Канада - Енглески - Health Canada

juno pharmaceuticals corp. - micafungin (micafungin sodium) - powder for solution - 50mg - micafungin (micafungin sodium) 50mg

Канада - Енглески - Health Canada

hikma canada limited - micafungin sodium - powder for solution - 50mg - micafungin sodium 50mg

Канада - Енглески - Health Canada

hikma canada limited - micafungin sodium - powder for solution - 100mg - micafungin sodium 100mg

Канада - Енглески - Health Canada

accord healthcare inc - micafungin (micafungin sodium) - powder for solution - 50mg - micafungin (micafungin sodium) 50mg

Канада - Енглески - Health Canada

accord healthcare inc - micafungin (micafungin sodium) - powder for solution - 100mg - micafungin (micafungin sodium) 100mg

Израел - Енглески - Ministry of Health

ofek pharma ltd, israel - micafungin as sodium - powder for concentrate for solution for infusion - micafungin as sodium 100 mg - micafungin - adults, adolescents ≥ 16 years of age and elderly: treatment of invasive candidiasis. treatment of esophageal candidiasis in patients for whom intravenous therapy is appropriate. prophylaxis of candida infections in patients undergoing allogeneic hematopoietic stem cell transplantation. children (including neonates) and adolescents < 16 years of age: treatment of invasive candidiasis. prophylaxis of candida in patient undergoing hematopoietic stem cell transplantation. the decision to use micafungin should take into account a potential risk for the development of the liver. micafungin should therefore only be used if other antifungals are not appropriate

Израел - Енглески - Ministry of Health

ofek pharma ltd, israel - micafungin as sodium - powder for concentrate for solution for infusion - micafungin as sodium 50 mg - micafungin - adults, adolescents ≥ 16 years of age and elderly: treatment of invasive candidiasis. treatment of esophageal candidiasis in patients for whom intravenous therapy is appropriate. prophylaxis of candida infections in patients undergoing allogeneic hematopoietic stem cell transplantation. children (including neonates) and adolescents < 16 years of age: treatment of invasive candidiasis. prophylaxis of candida in patient undergoing hematopoietic stem cell transplantation. the decision to use micafungin should take into account a potential risk for the development of the liver. micafungin should therefore only be used if other antifungals are not appropriate

Израел - Енглески - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - micafungin as sodium - powder for concentrate for solution for infusion - micafungin as sodium 100 mg - micafungin - adults, adolescents ≥16 years of age and elderly:- treatment of invasive candidiasis.- treatment of esophageal candidiasis in patients for whom intravenous therapy is appropriate.- prophylaxis of candida infection in patients undergoing allogeneic haematopoietic stem cell transplantation.children (including neonates) and adolescents < 16 years of age:- treatment of invasive candidiasis.- prophylaxis of candida infection in patients undergoing allogeneic haematopoietic stem cell transplantation.the decision to use micafungin s.k. should take into account a potential risk for the development of liver tumours. micafungin s.k. should therefore only be used if other antifungals are not appropriate.

Израел - Енглески - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - micafungin as sodium - powder for concentrate for solution for infusion - micafungin as sodium 50 mg - micafungin - adults, adolescents ≥16 years of age and elderly:- treatment of invasive candidiasis.- treatment of esophageal candidiasis in patients for whom intravenous therapy is appropriate.- prophylaxis of candida infection in patients undergoing allogeneic haematopoietic stem cell transplantation.children (including neonates) and adolescents < 16 years of age:- treatment of invasive candidiasis.- prophylaxis of candida infection in patients undergoing allogeneic haematopoietic stem cell transplantation.the decision to use micafungin s.k. should take into account a potential risk for the development of liver tumours. micafungin s.k. should therefore only be used if other antifungals are not appropriate.